Medtronic Reports MHLW’s Shonin Approval and Launches Valiant Navion Thoracic Stent Graft System in Japan

 Medtronic Reports MHLW’s Shonin Approval and Launches Valiant Navion Thoracic Stent Graft System in Japan

Medtronic Reports MHLW’s Shonin Approval and Launches Valiant Navion Thoracic Stent Graft System in Japan

Shots:

  • Medtronic has received MHLW’s approval & launches Valiant Navion thoracic stent graft system for the minimally invasive repair of thoracic descending aortic aneurysms (TAA) and complicated type B aortic dissections (TBAD)
  • With Valiant Navion, Medtronic sets out to offer a second stent-graft option alongside its Valiant Captivia thoracic stent graft system. The Valiant Navion offers CoveredSeal (proximal covered) and FreeFlo (proximal bare metal) stent configurations for the treatment of challenging thoracic aorta pathologies
  • The launch marks the third geographical launch of the Valiant Navion, following FDA and CE Mark approvals in H2’2018. The lower-profile thoracic endovascular aortic repair (TEVAR) device broadens patient applicability and allowed for more patients to receive an endovascular repair

Click here to­ read full press release/ article | Ref: Medtronic | Image: Medtronics

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post